Role of low-molecular-weight heparins in the treatment of sudden hearing loss

Wen L Yue1, Pei Li, Pei Y Qi

  • 1Department of Otolaryngology, Pingdingshan People's Hospital, No 1, 117 you-yue Road, Pingdingshan City, Henan 467000, P.R. China.

Insights

Low-molecular-weight heparins significantly improve hearing recovery rates in sudden sensorineural hearing loss (SNHL) patients. This treatment offers a safer alternative to unfractionated heparins for SNHL therapy.

Area of Science:

  • Otolaryngology
  • Pharmacology

Background:

  • Sudden sensorineural hearing loss (SNHL) lacks a universally accepted definitive treatment.
  • Investigating novel therapeutic agents is crucial for improving SNHL outcomes.

Purpose of the Study:

  • To evaluate the efficacy of low-molecular-weight heparins (LMWHs) as an adjunct therapy for SNHL.
  • To compare audiometric outcomes in SNHL patients treated with and without LMWHs.

Main Methods:

  • Retrospective analysis of 100 SNHL patients divided into two groups.
  • Group 1 received standard therapy plus LMWHs; Group 2 received standard therapy alone.
  • Audiometric data were compared pre-treatment, at day 10, and at follow-up (average 20 days).

Main Results:

  • Significant improvement in early and late audiometric outcomes was observed in the LMWH group (Group 1) compared to the control group (Group 2) (P < .05).
  • Recovery or good improvement was noted in 86% of patients in Group 1, significantly higher than in Group 2 (P < .01).
  • The average improvement rate was 84% in Group 1.

Conclusions:

  • Low-molecular-weight heparins significantly enhance the curative rate for hearing improvement in sudden sensorineural hearing loss.
  • LMWHs present a therapeutic option for SNHL without the potential risks associated with unfractionated heparins.
Abstract

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...